pharma · Colorectal Cancer · Cancer · GDTC
CytoMed Therapeutics
CytoMed Therapeutics Ltd
CytoMed Therapeutics is a pharma organization headquartered in 1 COMMONWEALTH LANE, U0, SG. It trades on NYSE under ticker GDTC. Primary therapeutic focus areas include Colorectal Cancer, Cancer, Aging Well, Lupus Nephri
1 COMMONWEALTH LANE, U0, SG HQ
2018 Founded
26 Employees
Public company Type
GDTC · NYSE Ticker
Company details
- Status
- Public
- HQ
- 1 COMMONWEALTH LANE, U0, SG
- Founded
- 2018
- Employees
- 26
- Programs
- 4
- Drugs
- 12
- Patents
- 3
human Mesenchymal Stem Cell (MSC) infusion therapy
Phase 1 · mab · Aging Well
human Mesenchymal Stem Cell (MSC) infusion therapy for Aging Well is a Phase 1 program (mab) at CytoMed Therapeutics Ltd with 1 ClinicalTrials.gov record(s).
Internal code Protocol LMC-101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- CytoMed Therapeutics Ltd
- Phase
- Phase 1
- Modality
- mab
- Indication
- Aging Well
- Status
- active
- Trials
- 1